Antigen recognition by human T cell receptor gamma-positive lymphocytes. Specific lysis of allogeneic cells after activation in mixed lymphocyte culture by unknown
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The surface molecules that serve as receptor for antigen/MHC recognition
are composed of a disulphide a/,Q heterodimer that is noncovalently associated
with CD3, a multipolypeptide cell membrane complex (1, 2). In addition, a
minor cell subset has recently been identified that expressed CD3-associated
structures that represent the molecular product of the TCR-y gene (3). TCR-
y+ cells differ from typical TCR-a/#+ T cells for both phenotypic and functional
properties. Thus, they lack both CD4 and CD8 differentiation antigens, which
are known to identify the two major peripheral T cell subpopulations; they also
lack CD28 (4), a surface molecule involved in the activation of typical TCR-a/0
cells, but express CDI1 and LAK-1, surface markers expressed by human NK
cells (5). In addition, virtually all TCR-y+ cells give rise to cytolytic clonal pro-
genies with lytic activity against a variety of tumor target cells (6). Previous stud-
ies have shown that stimuli acting on the TCR/CD3 molecular complex induce
TCR-y+ cells to express their functional program (including lymphokine pro-
duction and activation of the lytic machinery) in a manner that is indistinguish-
able from conventional TCR-a/#+ cells (7). However, no information is so far
available on the natural ligand responsible for human TCR-y+ cell activation.
The fact that the TCR-y chain, similarly to a and 0 chains, is formed by multiple
rearranging genes that code for variable regions, supports the idea that anti-
gen(s) may be the natural ligand(s) also for TCR-y+ cells. In an attempt to verify
this hypothesis, we analyzed the ability ofTCR-,y+ cells to recognize alloantigens.
We show that purified CD4-8- TCR-y+ cells can proliferate in response to allo-
geneic cells in MLC; the resulting MLC populations display a strong cytolytic
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activity against specific target cells (but not against unrelated or autologous tar-
gets). In addition, the expression of CD3-associated molecules different from
TCR-a and -,8 chains, together with the detection of y mRNA and the lack of a
and 0 mRNAs, suggests that CD3+4-8- MLC-activated populations indeed
express the TCR-y gene product. Finally, several TCR-7' clones have been
obtained from different individuals, which display a restricted cytolytic pattern.
Materials and Methods
Isolation of CD3'4-8` Lymphocytes, MLC, Evaluation of Cytolytic Activity and Cell Clon-
ing. Peripheral blood lymphocytes from normal volunteers were isolated by Ficoll-
Hypaque (F-H) gradients and separated into E rosetting-positive (E+) and -negative (E-)
populations. E-rosetting cells were then incubated with a mixture of anti-CD4 and anti-
CD8 mAbs followed by treatment with rabbit complement for 1 h at 37°C. Viable cells
were isolated by F-H gradients and cultured in microwells (5 X 104 cells/well) in the
presence of autologous or allogeneic irradiated feeder cells; after 7 d the cultures were
supplemented with 100 U/ml of rIL-2 (Cetus Corp., Emeryville, CA). The MLC-derived
cells were cloned under limiting diluition conditions in the presence of allogeneic irra-
diated feeder cells and 100 U/ml of rIL-2. The mAbs used in these experiments were
the following: Leu-4 (anti-CD3) (Becton Dickinson & Co., Basel, Switzerland), HP26
(anti-CD4), B9.4 (anti-CD8), and MAR 206 (anti-CD2) (prepared in our laboratory; ref-
erence 7); WT31 (directed to a framework determinant of the TCR-a/#) (Sambio, Uden,
The Netherlands).
The degree of cell proliferation in MLC was evaluated after 10 d of culture as the
arithmetic mean of the number of cells recovered from six wells of each experimental
group, or by the uptake of [6H]thymidine, added 18 h before harvesting. The cytolytic
activity was tested in a 4-h "Cr-release assay, in which varying numbers of effector cells
were tested against one or another o£ the following target cells: NK-sensitive K562 cells,
fresh uncultured melanoma cells derived from a malignant ascites, PHA-blasts derived
from the same source of lymphocytes used as stimulating cells in MLC (or unrelated
lymphocytes, as control). PHA blasts were obtained by culturing PBL for 4 d with 0.5%
PHA (vol/vol) in the presence of rIL-2 (100 U/ml). In all instances, target cells were
used at 5 X 103/well, for a final effector/target ratio ranging between 25:1 and 1 .5 :1.
Percent specific lysis was determined as previously described (8) .
Immunoprecipitation.
￿
Cells (5 X 106) were radioiodinated by the lactoperoxidase tech-
nique, lysed under conditions which preserve the CD3-TCR complex (in a buffer con-
taining 1% digitonin) and immunoprecipitated as described (5, 7). After immunoprecip-
itation, samples were examined by SDS-PAGE under nonreducing or reducing conditions
using 5% 2-ME, which cleaves disulfide bonds between protein subunits.
Northern Blot Analysis.
￿
Total cellular RNA was extracted from frozen cell pellets by
the guanidinium thiocyanate method and purified by centrifugation through a CsCl gra-
dient. RNA was size fractionated by electrophoresis in a 1.5% agarose gel containing
formaldehyde in MOPS buffer and blotted into nitrocellulose buffer. Filter hybridization
to the s2P-labeled DNA probes and washings were performed as previously described (5).
The cDNA probes for TCR-a and 0 chains were kindly provided by Dr. Tak Mak (9),
whereas, for TCR-y, we used a genomic probe containing the 3' half of the first exon of
the GyI gene (a kind gift of Dr. T. Rabbitts, Cambridge, U. K.) (10).
Results and Discussion
Enriched CD3+4`8" WT31 - cells were derived from peripheral E-rosetting
cells by treatment with anti-CD4 plus anti-CD8 mAbs and complement. The
resulting populations (2-10% of the starting cells) were CD4- and CD8 -, >99%
were CD2 + and contained variable proportions of CD3+ cells (40-90%). <2%
of treated cells were reactive with the WT31 mAb. Further purification basedCICCONE ET AL .
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on the positive selection of CD3 + cells was not applied, since such selection
would result in antibody-induced CD3/TCR modulation which could interfere
with alloantigen recognition . Enriched CD3 +CD4-8- cells were cultured in
microwells with allogeneic or autologous irradiated mononuclear cells . IL-2 was
added 7 d after initiation of the cultures and proliferation was evaluated 3 d
later . Cell proliferation was evaluated either as [sH]TdR uptake or as number
of recovered cells/well . Specific cell proliferation in response to allogeneic cells
(up to eightfold increase of the initial number ofresponding cells cultured) was
detected in three of five individuals tested. In addition, most MLC-derived
CD3+ cells were also stained by an anti-TCR-y mAb recently derived in our lab-
oratory (manuscript in preparation) . As indicated by surface marker analysis, the
resulting MLC populations contained < 1% WT31 + or CD4+ or CD8 + cells. As
shown in Fig. 1, these MLC responsive cells lysed "Cr-labeled PHA-induced
blasts derived from the allogeneic stimulating cells, but not autologous or unre-
lated blasts (A) . In contrast, the same population cultured with autologous irra-
diated cells did not develop any cytolytic activity, neither against autologous nor
against allogeneic target cells (B) . The cytolytic pattern of MLC-stimulated
CD3'4 -8-WT31 - cells in both allogeneic and autologous MLC was comparable
to that of MLC-stimulated TCR-a/#' cell populations derived from the same
donor (Fig . 1, C and D) . To determine the nature of CD3-associated molecules
expressed by alloreactive CD3 +4-8-WT31 - cells, we performed surface labeling
experiments, followed by lysis under conditions that preserve the CD3-TCR
complex association, and immunoprecipitation with anti-CD3 mAbs . These
experiments showed that, in two individuals analyzed (Fig. 2, panel I), CD3-
associated molecules consisted of two bands of 45 and 43 kD, respectively
FIGURE 1. MLC-activated CD3+4-8-WT31 - cells specifically lyse allogeneic target cells .
Cells were stimulated in MLC as described in Materials and Methods and tested for cytolytic
activity against different "Cr-labeled PHA-induced target cells . (A) CD3+4-8-WT31 - cells
cultured with the allogeneic cells a lysed only target cells a, but not allogeneic target cells b
or autologous cells . (B) Thesame cell population, after culture in the presence of autologous
lymphocytes, wasunable to lyse both autologous or allogeneic target cells. (C andD) Effector
cells were represented by CD3+WT31+ cells derived from the same donor and activated
either against allogeneic cells a or against autologous lymphocytes . Allogeneic target cells a,
"; allogeneic target cells b, / ; autologous target cells, A, .1520
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(under reducing conditions) . The same two chains were immunoprecipitated by
anti--y peptide antisera (1-6) as well as by a recently derived anti-TCR-'y mAb
(data not shown). Similar CD3-associated molecules were previously detected in
immunoprecipitates from CD3 +4- 8 -WT31 - clones or populations derived from
normal peripheral blood (5, 7). We further investigated whether mRNAs for
different TCR chains could be detected in polyclonal CD3+WT31 - alloreactive
cell populations. Northern blot analysis (Fig. 2, panel 2) clearly demonstrated
the presence of mature mRNA for the 'Y chain, while the mRNAs for the a and
,0 chains were absent. All together, these data support the notion that the 'gene
molecular product and not a or (3 chains were associated to CD3 molecules in
our CD3+4 -8-WT31 - alloreactive populations. We can therefore conclude that
cells expressing TCR y can specifically recognize and lyse allogeneic cells.
To further document the ability of TCR-y+ cells to specifically recognize (allo)
antigens, we derived several clones from MLC-stimulated CD3+4 - 8"WT31 -
populations. In all instances the clones analyzed expressed the original
CD2+3 +4"8 - WT31 - phenotype (not shown) . The cytolytic pattern of seven rep-
resentative clones is shown in Table I. It is evident that the clones maintained
the same cytolytic capability of the original MLC population. Thus, only specific
allogeneic target cells, but not autologous or unrelated allogeneic ones, were
lysed. Moreover, the specific cytolytic activity against allogeneic cells was not
necessarily linked to the expression of MHC-unrestricted cytotoxicity against
NK-sensitive or NKresistant tumor target cells. In fact, clone CI I lysed specific
allogeneic cells and K562, but not fresh melanoma cells. In addition, allospecific
E42 and C19 clones lysed neither K562 nor melanoma target cells. The finding
of a clonal heterogeneity in the ability to lyse K562 or melanoma cells is in
agreement with previous data on CD3 +4"8 -WT31 - unselected clones derived
from peripheral blood (5). Although our present data do not provide informa-
tion on the amplitude of the TCR-y functional repertoire, this may be suffi-
ciently wide to allow recognition of antigens present on allogeneic cells. In addi-
tion, it should be stressed that TCR-y+ alloreactive clones have been successfully
derived from different individuals. Whether the recognized antigens are repre-
TABLE I
Cytolytic Activity ofAllogeneic MLC-derived CD3+4-8-WT31- Clones
are expressed as percent specific "Cr-release at a lymphocyte/target
of -3:1.
"Cr-labeled target cells
Clone Autologous
PHA blasts
Specific
allogeneic
PHAblasts
Nonspecific
allogeneic
PHAblasts
Fresh
melanoma
cells K562
E 60 0* 22 0 11 10
E 90 0 44 8 36 100
E42 0 20 0 2 4
E93 0 34 1 59 100
C 11 0 16 ND 0 30
C 19 0 17 ND 0 0
M 14 0 19 ND ND NDCICCONE ET AL .
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FIGURE 2.
￿
(1) Immunoprecipitation and SDS-PAGE analysis of the CD3-associated mole-
cules expressed in allogeneic MLC-stimulated CD3+4-8-WT31 - cells (A and B) and in the
CD3+4-8-WT31 - clone 6.6 .1 . (C) Under nonreducing conditions (B) or under reducing
conditions (A andQ. (2) Northern blot analysis ofTCR gene products in allogeneic MLC-
stimulated CD3+4-8-WT31 - cells (A) and in the PEER cell line (B) . The blotswere hybrid-
ized to the TCR-a, -0, and -y probes .
sented by MHC-encoded molecules remains to be determined . In a preliminary
experiment with a TCR- ,y+ alloreactive clone, anti-class I but not anti-class 11
mAbs inhibited the specific lysis of allogeneic cells, when added to the cytolytic
assay . Along this line, it has been reported that TCR-y+ cells isolated from
alloimmunized BALB/c nu/nu mice may recognize class I MHC molecules (11) .
Summary
These experiments were designed to define the ability ofhuman TCR-y+ cells
to recognize allogeneic cells . TCR-y+-enriched populations were obtained by
treating peripheral blood E-rosetting cells with anti-CD4 and anti-CD8 mAbs .
The resulting populations were CD2+4-8- expressed variable proportions of
CD3+ cells (40-90%), and did not react with the WT31 mAb, which is specific
for a framework determinant of the a/# heterodimer that serves as receptor for
antigen on most human T lymphocytes. After mixed lymphocyte culture with
irradiated allogeneic cells for 7 d and 3 additional days in rIL-2 (100 U/ml),
cells underwent proliferation in three of five individuals tested. In addition,
MLC-derived cells lysed "Cr-labeled PHA-induced blasts derived from the allo-
geneic cells used as stimulator, but not allogeneic unrelated or autologous blast
cells. No cytotoxicity against autologous or allogeneic target cells could be
induced by culturing CD3+4"8-WT31 - lymphocytes in MLC with irradiated
autologous cells . Surface iodination of allogeneic MLC-activated
CD3+4-8-WT31 - cells followed by lysis in 1% digitonin and immunoprecipita-
tion with anti-CD3 mAb indicated that the CD3-associated molecules consisted
of a major 45-kD band and a minor band of 43 kD . Northern blot analysis1522
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showed that mRNA for the y chain was expressed at high levels, whereas
mRNAs for a and a chains were missing. These data support the notion that
TCR-y rather than TCR-a/0 is expressed in allospecific CD3-4-8-WT31 -
cell populations. Clones were further derived from MLC-stimulated
CD3+4- 8-WT31- populations. All the seven clones studied in detail main-
tained the surface phenotype as well as the cytolytic pattern of the original MLC
populations, thus only specific allogeneic PHA-induced blasts were lysed. NK-
sensitive as well as NK-resistant tumor targets were variably susceptible to lysis;
therefore, specific cytolytic activity against allogeneic cells was not necessarily
linked to the expression of MHC-nonrestricted cytotoxicity against tumor cells.
Receivedfor publication 4 January 1988.
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